Molecular targets and mechanisms of radiosensitization using DNA damage response pathways
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular targets and mechanisms of radiosensitization using DNA damage response pathways
Authors
Keywords
-
Journal
Future Oncology
Volume 9, Issue 2, Pages 219-233
Publisher
Future Medicine Ltd
Online
2013-02-15
DOI
10.2217/fon.12.185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new role for ATM
- (2012) Yasmine A. Valentin-Vega et al. Autophagy
- Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
- (2012) I M Pires et al. BRITISH JOURNAL OF CANCER
- The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy
- (2012) Remko Prevo et al. CANCER BIOLOGY & THERAPY
- Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1
- (2012) Sean Vance et al. CELL CYCLE
- Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control
- (2012) Sarah E. Golding et al. CELL CYCLE
- Molecular Parameters of Hyperthermia for Radiosensitization
- (2012) Tej K. Pandita et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors
- (2012) Rebeka Sultana et al. INTERNATIONAL JOURNAL OF CANCER
- Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice
- (2012) Kenta Yamamoto et al. JOURNAL OF CELL BIOLOGY
- Loss of ATM kinase activity leads to embryonic lethality in mice
- (2012) Jeremy A. Daniel et al. JOURNAL OF CELL BIOLOGY
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme
- (2012) Dong Yang et al. PLoS One
- Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours
- (2011) A Reiman et al. BRITISH JOURNAL OF CANCER
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
- (2011) D. Wei et al. CANCER RESEARCH
- CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
- (2011) Victoria E. Anderson et al. CANCER RESEARCH
- A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
- (2011) Simon Pacey et al. CLINICAL CANCER RESEARCH
- SUMOylation and de-SUMOylation in response to DNA damage
- (2011) Hong Dou et al. FEBS LETTERS
- Congenital bone marrow failure in DNA-PKcs mutant mice associated with deficiencies in DNA repair
- (2011) Shichuan Zhang et al. JOURNAL OF CELL BIOLOGY
- Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites
- (2011) R. Montano et al. MOLECULAR CANCER THERAPEUTICS
- p50 (NF-κB1) Is an Effector Protein in the Cytotoxic Response to DNA Methylation Damage
- (2011) Adam M. Schmitt et al. MOLECULAR CELL
- Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
- (2011) Luis I. Toledo et al. Molecular Oncology
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2Checkpoint and Inhibition of Homologous Recombinational DNA Repair
- (2010) Meredith A. Morgan et al. CANCER RESEARCH
- Radiosensitization by Chir-124, a selective Chk1 inhibitor: Effects of p53 and cell cycle checkpoints
- (2010) Yungan Tao et al. CELL CYCLE
- Mechanism of p53 stabilization by ATM after DNA damage
- (2010) Qian Cheng et al. CELL CYCLE
- Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target
- (2010) L. Jia et al. CLINICAL CANCER RESEARCH
- New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
- (2010) Y. Dai et al. CLINICAL CANCER RESEARCH
- Hyperthermia alters the interaction of proteins of the Mre11 complex in irradiated cells
- (2010) Bogdan I. Gerashchenko et al. CYTOMETRY PART A
- The ubiquitous role of ubiquitin in the DNA damage response
- (2010) Abdallah Al-Hakim et al. DNA REPAIR
- RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase Is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins
- (2010) Lijun Jia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- ATM Activation by Oxidative Stress
- (2010) Z. Guo et al. SCIENCE
- ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence
- (2009) L. Jia et al. CANCER RESEARCH
- RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins
- (2009) Carsten Doil et al. CELL
- Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer
- (2009) T. A. Soucy et al. CLINICAL CANCER RESEARCH
- Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response
- (2009) Travis H. Stracker et al. DNA REPAIR
- Clinical Radiation Sensitivity With DNA Repair Disorders: An Overview
- (2009) Julianne M. Pollard et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cellular Inhibition of Checkpoint Kinase 2 (Chk2) and Potentiation of Camptothecins and Radiation by the Novel Chk2 Inhibitor PV1019 [7-Nitro-1H-indole-2-carboxylic acid -amide]
- (2009) A. G. Jobson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
- (2009) Shinji Mizuarai et al. Molecular Cancer
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
- (2009) L. A. Parsels et al. MOLECULAR CANCER THERAPEUTICS
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Multiple functions of MRN in end-joining pathways during isotype class switching
- (2009) Maria Dinkelmann et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
- (2008) A. N. Tse et al. CLINICAL CANCER RESEARCH
- Induction of a pro-apoptotic ATM–NF-κB pathway and its repression by ATR in response to replication stress
- (2008) Zhao-Hui Wu et al. EMBO JOURNAL
- Radiosensitization of cervical cancer cells via double-strand DNA break repair inhibition
- (2008) Christa B. Fuhrman et al. GYNECOLOGIC ONCOLOGY
- Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
- (2008) Masao Fujiwara et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Formation of Clustered DNA Damage after High-LET Irradiation: A Review
- (2008) Megumi HADA et al. JOURNAL OF RADIATION RESEARCH
- Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
- (2008) A. Blasina et al. MOLECULAR CANCER THERAPEUTICS
- AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
- (2008) S. D. Zabludoff et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started